Lipocine takes after-hours hit on negative panel vote

Lipocine Inc. (NASDAQ:LPCN) fell $1.88 (54%) to $1.58 in after-hours trading Wednesday on news that FDA's Bone, Reproductive and Urologic Drugs Advisory Committee voted

Read the full 240 word article

User Sign In